Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 211–225 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1019 DNA Profiling (Fingerprinting) Test This test generates a unique genetic profile based on short tandem repeat (STR) analysis from a blood sample.	3 mL Whole Blood (Lavender Top EDTA Tube)	5 working days	1,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Short Tandem Repeats (STRs)"] Parameters [] Preparation ["No dietary or medication restrictions are required.", "Bring a valid government-issued photo ID (Emirates ID or passport).", "Provide a signed consent form for DNA profiling (Form 34) at collection."] Indications ["Legal identification", "Medical identification", "Personal identification", "Paternity testing", "Forensic investigations", "Immigration purposes"] Measurement technique Confirm with laboratory Codes LOINC: 50397-9 ICD-10: Z04.8 Clinical summary This test generates a unique genetic profile based on short tandem repeat (STR) analysis from a blood sample.
TEST-225 DNA Short Insert Library Preparation Test This test prepares a DNA sample for next-generation sequencing (NGS) by fragmenting and labeling it.	Whole blood (EDTA) or extracted high-quality DNA	1 week	1,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DNA fragmentation", "Adapter ligation", "Library conversion efficiency"] Parameters [] Preparation ["Inform genetic counsellor about current medications prior to sample collection."] Indications ["Clinical genetic testing", "Forensic identification", "Biomedical research", "Preparation for NGS sequencing"] Measurement technique Confirm with laboratory Codes LOINC: 51962-8 ICD-10: Z13.79 Clinical summary This test prepares a DNA sample for next-generation sequencing (NGS) by fragmenting and labeling it.
TEST-278 DNA Viral Genome Sequencing and Analysis Test This test sequences the entire DNA genome of viruses present in a sample. It identifies specific viral strains and integration events.	Whole blood or extracted DNA	8 weeks	3,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Viral DNA genome sequence", "Viral strain identification", "Viral integration into host chromosomes"] Parameters [] Preparation ["No routine fasting required", "Inform team about blood-thinning medications"] Indications ["Diagnosis of viral infections", "Monitoring viral load", "Guiding antiviral therapy", "Identifying novel viral variants"] Measurement technique Confirm with laboratory Codes LOINC: 60524-3 ICD-10: B34.9 Clinical summary This test sequences the entire DNA genome of viruses present in a sample. It identifies specific viral strains and integration events.
TEST-247 DNA Viral Genome Sequencing Test This test identifies viral pathogens present in a sample by sequencing their DNA genomes.	Whole blood (peripheral), extracted DNA accepted	5 weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Viral DNA sequences", "Viral resistance mutations", "Viral load (relative abundance)"] Parameters [] Preparation [] Indications ["Definitive diagnosis of viral infections", "Detection of novel or rare viruses", "Identification of antiviral resistance mutations", "Evaluation in transplant recipients", "Suspected congenital viral infections"] Measurement technique Confirm with laboratory Codes LOINC: 87806-0 ICD-10: B34.9 Clinical summary This test identifies viral pathogens present in a sample by sequencing their DNA genomes.
TEST-5832 DNAJB2 Gene Spinal Muscular Atrophy Type 5 (SMA5) Test This genetic test identifies pathogenic variants in the DNAJB2 gene associated with Spinal Muscular Atrophy Type 5.	Whole Blood, EDTA (Lavender Top)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DNAJB2 gene"] Parameters [] Preparation ["No special dietary or medication adjustments are needed."] Indications ["Suspected Spinal Muscular Atrophy Type 5", "Family history of SMA5"] Measurement technique Confirm with laboratory Codes LOINC: 69047-9 ICD-10: G12.1 Clinical summary This genetic test identifies pathogenic variants in the DNAJB2 gene associated with Spinal Muscular Atrophy Type 5.
TEST-4524 DNASE1L3 Gene Systemic Lupus Erythematosus Type 16 Genetic Test This test identifies pathogenic variants within the DNASE1L3 gene associated with autosomal recessive Systemic Lupus Erythematosus type 16.	Peripheral Whole Blood or FTA Card	3–4 Weeks (Expedited available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DNASE1L3 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of severe bleeding disorders"] Indications ["Diagnosis of SLE16", "Familial risk assessment for SLE16", "Personalized disease management for SLE16"] Measurement technique Confirm with laboratory Codes LOINC: 82145-5 ICD-10: M32.9 Clinical summary This test identifies pathogenic variants within the DNASE1L3 gene associated with autosomal recessive Systemic Lupus Erythematosus type 16.
TEST-2146 DNMT3A Somatic Mutation Analysis for Acute Myeloid Leukemia (NGS) Test This test identifies somatic mutations within the DNMT3A gene in a patient's blood or bone marrow sample.	Peripheral Whole Blood, Bone Marrow Aspirate	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DNMT3A gene somatic mutations"] Parameters [] Preparation ["Inform phlebotomist of recent blood transfusions (within 7 days).", "No specific fasting required."] Indications ["Diagnosis of Acute Myeloid Leukemia (AML)", "Prognostic assessment in AML", "Guiding therapeutic decisions in AML", "Clinical trial eligibility assessment"] Measurement technique Confirm with laboratory Codes LOINC: 91798-3 ICD-10: C92.00 Clinical summary This test identifies somatic mutations within the DNMT3A gene in a patient's blood or bone marrow sample.
TEST-3405 DPY19L2 Gene (SPGF9) Genetic Test This test detects pathogenic variants, including deletions and point mutations, in the DPY19L2 gene associated with globozoospermia.	Peripheral Whole Blood or Buccal Swab	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DPY19L2 gene variants (SNVs)", "DPY19L2 gene copy number variations (CNVs)", "Pathogenic mutations causing globozoospermia"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Clinical suspicion of globozoospermia based on semen analysis", "Known family history of DPY19L2 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: N46.9, Z31.41, Z13.79 Clinical summary This test detects pathogenic variants, including deletions and point mutations, in the DPY19L2 gene associated with globozoospermia.
TEST-6342 DPYD Gene Dihydropyrimidine Dehydrogenase Deficiency Genetic Test This genetic test evaluates the DPYD gene for variants associated with dihydropyrimidine dehydrogenase deficiency, predicting risk of severe toxicity to fluoropyrimidine chemothera...	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DPYD gene variants", "Enzyme deficiency risk"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "99.9% (detects rare/novel variants)"}, {"name": "Methodology", "reference_range": "Next-Generation Sequencing (NGS) with full gene coverage and CNV analysis"}] Preparation ["Mandatory genetic counselling session", "Provide complete clinical history"] Indications ["Patients scheduled to receive 5‑fluorouracil or capecitabine", "Patients with family history of severe drug reactions"] Measurement technique Confirm with laboratory Codes LOINC: 94213-5 ICD-10: Z13.89 Clinical summary This genetic test evaluates the DPYD gene for variants associated with dihydropyrimidine dehydrogenase deficiency, predicting risk of severe toxicity to fluoropyrimidine chemotherapy.
TEST-3459 DUOX2 Gene Thyroid Dyshormonogenesis Type 6 Genetic Test This test identifies pathogenic variants in the DUOX2 gene associated with thyroid dyshormonogenesis type 6, a form of congenital hypothyroidism.	Peripheral whole blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DUOX2 gene", "Deletion/duplication analysis of the DUOX2 gene"] Parameters [] Preparation ["Patients on high-dose biotin supplements must pause intake 48 hours before blood draw."] Indications ["Diagnosis of thyroid dyshormonogenesis type 6", "Family screening for DUOX2 mutations", "Informed reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 97271-5 ICD-10: E03.1, Z14.8, Z84.8 Clinical summary This test identifies pathogenic variants in the DUOX2 gene associated with thyroid dyshormonogenesis type 6, a form of congenital hypothyroidism.
TEST-5501 DYX1C1 Gene Primary Ciliary Dyskinesia Type 25 Genetic Test This genetic test identifies pathogenic variants in the DYX1C1 gene associated with Primary Ciliary Dyskinesia Type 25.	Whole blood (EDTA), extracted DNA, dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DYX1C1 gene", "Missense, nonsense, splicing variants, small deletions"] Parameters [] Preparation [] Indications ["Suspected Primary Ciliary Dyskinesia Type 25", "Family history of PCD25", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 93385-3 ICD-10: Q34.8, Z15.01, Z82.79 Clinical summary This genetic test identifies pathogenic variants in the DYX1C1 gene associated with Primary Ciliary Dyskinesia Type 25.
TEST-1623 Early Infantile Epileptic Encephalopathy (EIEE) Gene Panel Test This test identifies genetic mutations associated with severe early-onset epilepsy syndromes.	Peripheral whole blood; Amniotic fluid; Chorionic villus	4–6 weeks	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetic variants in >50 genes associated with EIEE", "Single nucleotide variants", "Copy number variations"] Parameters [] Preparation ["No specific patient preparation required", "Ensure valid sample collection"] Indications ["Diagnosis of suspected EIEE", "Identification of genetic cause for early-onset epilepsy", "Guiding antiepileptic therapy", "Family counseling"] Measurement technique Confirm with laboratory Codes LOINC: 90270-5 ICD-10: G40.4 Clinical summary This test identifies genetic mutations associated with severe early-onset epilepsy syndromes.
TEST-2097 EGFR Gene Exons 18‑21 Selective Sequencing (NGS) Genetic Test This test identifies specific mutations in the EGFR gene (exons 18-21) relevant to non-small cell lung cancer treatment.	Peripheral Whole Blood or DNA Specimen (FTA Card / Whole Blood Tube)	15-20 business days (3-4 weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR gene mutations (SNVs, insertions, deletions)", "Variant Allele Frequency (VAF) down to 0.1%"] Parameters [] Preparation [] Indications ["Advanced non-small cell lung cancer", "Guidance for tyrosine kinase inhibitor therapy"] Measurement technique Confirm with laboratory Codes LOINC: 57186-8 ICD-10: C34.9, Z85.1 Clinical summary This test identifies specific mutations in the EGFR gene (exons 18-21) relevant to non-small cell lung cancer treatment.
TEST-1021 EGFR Mutational Analysis Test This test identifies activating and resistance mutations in the EGFR gene from FFPE tumor tissue to guide targeted lung cancer therapy.	Formalin-Fixed Paraffin-Embedded (FFPE) Tumour Block / Archival Tissue	5 Working Days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR gene mutations", "Activating mutations", "Resistance mutations (e.g., T790M, exon 20 insertions)"] Parameters [{"name": "Exons 18–21 Mutations", "reference_range": "Negative / Positive"}, {"name": "T790M Mutation", "reference_range": "Negative / Positive"}, {"name": "Exon 20 Insertions", "reference_range": "Negative / Positive"}, {"name": "Rare Mutations", "reference_range": "Negative / Positive"}] Preparation ["No fasting required", "Ensure histopathology report and completed requisition form are available"] Indications ["Diagnosis of non-small cell lung cancer (NSCLC)", "Guidance for targeted therapy selection", "Monitoring for resistance mutations"] Measurement technique Confirm with laboratory Codes LOINC: 21631-8 ICD-10: C34.9 Clinical summary This test identifies activating and resistance mutations in the EGFR gene from FFPE tumor tissue to guide targeted lung cancer therapy.
TEST-1901 ELAC2 Gene Prostate Cancer Susceptibility Test This test identifies pathogenic variants in the ELAC2 gene associated with hereditary prostate cancer risk.	Whole Blood (peripheral, 3-5 mL) or Extracted DNA	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ELAC2 gene"] Parameters [] Preparation [] Indications ["Individuals with a family history of prostate cancer", "Individuals seeking proactive health insight"] Measurement technique Confirm with laboratory Codes LOINC: 94146-3 ICD-10: Z15.03 Clinical summary This test identifies pathogenic variants in the ELAC2 gene associated with hereditary prostate cancer risk.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories